Detection of Patients With Abnormal Water Distribution Based on Bioelectrical Impedance Analysis (BIA)

The aim of this clinical investigation is to prove that the seca mbca detects dialysis patients with abnormal water distribution correctly. Abnormal high water distribution is defined as more than 2 liters of Total Body Water (TBW) above a normal value range. TBW and Extra Cellular Water (ECW) are calculated with prediction equations for healthy subjects generated in BCA-01. The results are compared with TBW and ECW ascertained by dilution methods as standard reference methods. The Bioelectrical Impedance Analysis (BIA) method should be evaluated to the accuracy of the absolute measurement of the volume state of dialysis patients (euvolaemic and hypervolaemic) based on a single measurement.

Study Overview

• Status: Completed
• Conditions: Kidney Diseases
• Intervention / Treatment: Device: medical Body Composition Analyzer seca 514/515; Procedure: Deuterium and Sodium Bromide dilution methods

• Study Type: Observational
• Enrollment (Actual): 62

Contacts and Locations

Study Locations

• Germany
  • Berlin, Germany, 10117
    • Charite University Medicine Berlin

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Data of 50 patients suffering from kidney disease are planned to be collected.

Description

Inclusion Criteria:

The study will cover 50 adults. Men and women in an age range of 18 to 65 years and a Body Mass Index (BMI) range of 18.5 to 35 kg/m2 should be equally distributed. Subjects have to be patients with chronic kidney failure taking dialysis treatment. 25 patients are taken before and another 25 patients after this treatment. Patients that are taken before dialysis treatment should have been dialysed two and not three days before.

Exclusion Criteria:

• amputation of limbs
• gastrointestinal tract illnesses that influence the absorption of substances that are needed for dialysis
• bed-ridden patients patients with clinical relevant hypervolaemia or hypovolaemia
• electrical implant as cardiac pacemaker
• insulin pumps
• pregnancy or breastfeeding period
• subjects who cannot provide an Informed Consent Form (ICF) by themselves
• subjects who might be dependent from the sponsor or the investigation site

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patients before dialysis treatment	Device: medical Body Composition Analyzer seca 514/515; Current of 100 µA; Procedure: Deuterium and Sodium Bromide dilution methods; Orally administered to the subject in a solution with 100 ml tap water.
Patients after dialysis treatment	Device: medical Body Composition Analyzer seca 514/515; Current of 100 µA; Procedure: Deuterium and Sodium Bromide dilution methods; Orally administered to the subject in a solution with 100 ml tap water.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Bioelectrical impedance (Resistance and Reactance) of 5 and 50 kHz for the right body side	The measurements are utilized as input for prediction equations to calculate TBW and ECW.	about 2 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Bioelectrical impedance (Resistance and Reactance) of 1, 1.5, 2, 3, 7.5, 10, 15, 20, 30, 75, 100, 150, 200, 300, 500, 750 and 1,000 kHz	The measurement is planned to be done for all body segments: right arm, left arm, right leg, left leg, trunk, right body side and left body side. In total resistance and reactance at 19 frequencies for 7 body segments are to be measured.	about 2 minutes
TBW	A D2O dose of 400 mg per kg body weight mixed with tap water is administered orally in the morning fasting and after a 2 hour fluid abstention. The distribution of the stable isotope in the TBW is completed after 4 hours. During this period, the subject remains fasting. Two venous blood samples of 10 ml whole blood are taken immediately before and four hours after taking D2O. The plasma samples are analyzed using Isoptopic Ratio Mass Spectrometry (IRMS).	within 4 hours
ECW	Orally administered NaBr is resorbed quickly and completely and almost exclusively distributes in the extracellular compartment. Blood samples of 10 ml are taken immediately before and 4 hours after oral application of 50 mg NaBr per kg body weight. The serum sample is analyzed by X-Ray Fluorescence Spectroscopy (XRF).	within 4 hours

Collaborators and Investigators

• Sponsor: Seca GmbH & Co. Kg.
• Investigators: Principal Investigator: Torsten Slowinski, Dr., Charite University, Berlin, Germany

Study record dates

Study Major Dates

• Study Start: January 1, 2012
• Primary Completion (ACTUAL): August 1, 2012
• Study Completion (ACTUAL): August 1, 2012

Study Registration Dates

• First Submitted: November 10, 2011
• First Submitted That Met QC Criteria: November 23, 2011
• First Posted (ESTIMATE): November 29, 2011

Study Record Updates

• Last Update Posted (ESTIMATE): October 3, 2012
• Last Update Submitted That Met QC Criteria: October 2, 2012
• Last Verified: October 1, 2012

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Urologic Diseases; Kidney Diseases; Anticonvulsants; Bromides
• Other Study ID Numbers: BCA-05